Laparoscopic Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy, an Update From the International PSOGI Registry
Journal of Surgical Oncology · 2024
DOI: 10.1002/jso.27881 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Surgical Oncology, 2024. Verfasst von M Duran-Martínez und 4 weiteren Autor:innen. Beteiligte Einrichtung: Unit of Surgical Oncology, Reina Sofia University Hospital, Cordoba, Spain. Hauptthemen laut MEDLINE: Cytoreduction Surgical Procedures, Hyperthermic Intraperitoneal Chemotherapy, Laparoscopy, Peritoneal Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 23 Literaturangaben.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Introduction
Cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) are established treatments for peritoneal surface malignancies, traditionally performed via laparotomy. Recent advancements in laparoscopic approaches (L‐CRS + HIPEC) have shown promising results in selected patients.
Methods
The PSOGI registry, established in November 2019, collects data from specialized centers performing L‐CRS + HIPEC. Data were collected prospectively and analyzed retrospectively, excluding risk‐reducing procedures without peritoneal disease. The learning curve was assessed using a 14‐cases cutoff.
Results
Today, 323 patients have been registered, 193 were included finally. Perioperative outcomes improved after 14 cases: Length of hospital stay was 7.78 ± 3.64 days (consolidation) versus 8.8 ± 8.79 days (learning) and major morbidity was 0% (consolidation) versus 5% (learning), ( p = n.s.). Estimated blood loss was lower in the consolidation phase. Oncological outcomes also improved: Recurrence rate was 8.7% (consolidation) versus 17.8% (learning). Disease‐free survival 5 years, 65% (learning) versus 88% (consolidation) ( p = 0.012).
Conclusion
The L‐CRS + HIPEC is a safe procedure with non‐inferior oncologic outcomes which it is evaluating in an IDEAL setting by an international group. The validation of the learning curve, gives us the knowledge that a mentoring program must be setup to reduce the learning curve impact in oncologic failure.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Unit of Surgical Oncology, Reina Sofia University Hospital, Cordoba, Spain.
- Department of Biochemistry and Molecular Biology, GE09 Research in Peritoneal and Retroperitoneal Oncologic Surgery Group, Maimonides Biomedical Research Institute of Cordoba (IMIBIC), Reina Sofía University Hospital, U…
Zitieren
APA
Duran-Martínez, M., Bergillos-Giménez, M., Rodríguez-Ortíz, L., Arjona-Sánchez, A., & Laparoscopic PSOGI Registry (2024). Laparoscopic Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy, an Update From the International PSOGI Registry. Journal of Surgical Oncology. https://doi.org/10.1002/jso.27881
Vancouver
Duran-Martínez M, Bergillos-Giménez M, Rodríguez-Ortíz L, Arjona-Sánchez A, Laparoscopic PSOGI Registry. Laparoscopic Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy, an Update From the International PSOGI Registry. Journal of Surgical Oncology. 2024. doi:10.1002/jso.27881
BibTeX
@article{DuranMartnez2024,
author = {Duran-Martínez, M and Bergillos-Giménez, M and Rodríguez-Ortíz, L and Arjona-Sánchez, A and Laparoscopic PSOGI Registry, Laparoscopic PSOGI Registry},
title = {Laparoscopic Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy, an Update From the International PSOGI Registry},
journal = {Journal of Surgical Oncology},
year = {2024},
doi = {10.1002/jso.27881}
}
EUVIMED